{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:58:00Z","timestamp":1782255480663,"version":"3.54.5"},"reference-count":150,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","award":["20 0704; 20 0778"],"award-info":[{"award-number":["20 0704; 20 0778"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stockholm Cancer Society","award":["201092; 201242"],"award-info":[{"award-number":["201092; 201242"]}]},{"name":"Swedish Cancer and Allergy Foundation","award":["10127; 10137"],"award-info":[{"award-number":["10127; 10137"]}]},{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","award":["2018:2017"],"award-info":[{"award-number":["2018:2017"]}],"id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftelsen Clas Groschinsky Minnesfond","award":["M19376, and M2025"],"award-info":[{"award-number":["M19376, and M2025"]}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls stiftelse","doi-asserted-by":"publisher","award":["2020-03737"],"award-info":[{"award-number":["2020-03737"]}],"id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tornspiran","award":["Tornspiran"],"award-info":[{"award-number":["Tornspiran"]}]},{"name":"Stiftelsen Sigurd och Elsa Goljes Minne","award":["LA2019-0143; LA2020-0077; LA2020-0070"],"award-info":[{"award-number":["LA2019-0143; LA2020-0077; LA2020-0070"]}]},{"DOI":"10.13039\/501100003514","name":"Stockholm City Council","doi-asserted-by":"publisher","award":["20180037; 20200059"],"award-info":[{"award-number":["20180037; 20200059"]}],"id":[{"id":"10.13039\/501100003514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The incidence of Human-papillomavirus-positive (HPV+) tonsillar and base-of-tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) is increasing epidemically, but they have better prognosis than equivalent HPV-negative (HPV\u2212) cancers, with roughly 80% vs. 50% 3-year disease-free survival, respectively. The majority of HPV+ TSCC and BOTSCC patients therefore most likely do not require the intensified chemoradiotherapy given today to head and neck cancer patients and would with de-escalated therapy avoid several severe side effects. Moreover, for those with poor prognosis, survival has not improved, so better-tailored alternatives are urgently needed. In line with refined personalized medicine, recent studies have focused on identifying predictive markers and driver cancer genes useful for better stratifying patient treatment as well as for targeted therapy. This review presents some of these endeavors and briefly describes some recent experimental progress and some clinical trials with targeted therapy.<\/jats:p>","DOI":"10.3390\/v13050910","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T02:31:34Z","timestamp":1621218694000},"page":"910","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-4297","authenticated-orcid":false,"given":"Anders","family":"N\u00e4sman","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Holzhauser","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania N.","family":"Kostopoulou","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zupancic","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"\u00c4hrlund-Richter","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tumor Biology and Cellular Biology, Karolinska Institutet, Biomedicum, 171 77 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Bioclinicum J6:20, Karolinska University Hospital, 171 64 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"ref_1","unstructured":"IARC (2007). Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 90, International Agency for Research on Cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ijc.20490","article-title":"Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients","volume":"112","author":"Dahlgren","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G","article-title":"Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival","volume":"89","author":"Mellin","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/ijc.24994","article-title":"The role of human papillomavirus in the increased incidence of base of tongue cancer","volume":"126","author":"Attner","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.oraloncology.2009.03.010","article-title":"Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults","volume":"45","author":"Braakhuis","year":"2009","journal-title":"Oral Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.oraloncology.2005.10.018","article-title":"Incidence of oral and oropharyngeal cancer in United Kingdom (1990\u20131999)\u2014Recent trends and regional variation","volume":"42","author":"Conway","year":"2006","journal-title":"Oral Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hed.25585","article-title":"Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000\u20132016 in the Stockholm region and Sweden","volume":"41","author":"Haeggblom","year":"2019","journal-title":"Head Neck"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/00016480601110170","article-title":"The incidence of tonsillar cancer in Sweden is increasing","volume":"127","author":"Hammarstedt","year":"2007","journal-title":"Acta Otolaryngol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/ijc.22177","article-title":"Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer","volume":"119","author":"Hammarstedt","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: A virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?","volume":"125","author":"Nasman","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2014.10.016","article-title":"Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: A stabilisation of an epidemic of viral induced carcinoma?","volume":"51","author":"Nasman","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3201\/eid1611.100452","article-title":"Oropharyngeal cancer epidemic and human papillomavirus","volume":"16","author":"Ramqvist","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1368-8375(02)00014-3","article-title":"Oropharyngeal cancer incidence and mortality in Scotland: Are rates still increasing?","volume":"39","author":"Robinson","year":"2003","journal-title":"Oral Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/ijc.25625","article-title":"Human papillomavirus and survival in patients with base of tongue cancer","volume":"128","author":"Attner","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/lary.24296","article-title":"Temporal trends in oropharyngeal cancer treatment and survival: 1998\u20132009","volume":"124","author":"Chen","year":"2014","journal-title":"Laryngoscope"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1040-8428(01)00129-9","article-title":"Cancer of the oropharynx","volume":"41","author":"Licitra","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_22","unstructured":"(2021, April 07). Oropharyngeal Cancer Treatment (Adult) (PDQ\u00ae)\u2013Health Professional Version, Available online: https:\/\/www.cancer.gov\/types\/head-and-neck\/hp\/adult\/oropharyngeal-treatment-pdq."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.oraloncology.2017.03.007","article-title":"A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer","volume":"68","author":"Bersani","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.molonc.2007.08.005","article-title":"Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7","volume":"1","author":"Lindquist","year":"2007","journal-title":"Mol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.21037\/atm-20-2984","article-title":"De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma-a narrative review","volume":"8","author":"Strohl","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/djz224","article-title":"PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation","volume":"112","author":"Beaty","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.04.021","article-title":"MicroRNA-155, -185 and-193b as biomarkers in human papillomavirus positive and negative tonsillar and base of tongue squamous cell carcinoma","volume":"82","author":"Bersani","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35339","DOI":"10.18632\/oncotarget.15240","article-title":"Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3","volume":"8","author":"Bersani","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/s41416-018-0107-9","article-title":"Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: A European Multicentre Study (OroGrams)","volume":"118","author":"Gronhoj","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejca.2017.02.018","article-title":"MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma","volume":"77","author":"Hess","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1158\/1078-0432.CCR-12-3572","article-title":"Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma","volume":"19","author":"Hui","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med."},{"key":"ref_33","first-page":"153","article-title":"Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer","volume":"32","author":"Lindquist","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/bjc.2014.87","article-title":"Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer","volume":"110","author":"Lindquist","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nasman, A., Andersson, E., Marklund, L., Tertipis, N., Hammarstedt-Nordenvall, L., Attner, P., Nyberg, T., Masucci, G.V., Munck-Wikland, E., and Ramqvist, T. (2013). HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077025"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.27635","article-title":"MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome","volume":"132","author":"Nasman","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cam4.90","article-title":"Absent\/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival","volume":"2","author":"Nasman","year":"2013","journal-title":"Cancer Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nasman, A., Romanitan, M., Nordfors, C., Grun, N., Johansson, H., Hammarstedt, L., Marklund, L., Munck-Wikland, E., Dalianis, T., and Ramqvist, T. (2012). Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038711"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.ejca.2013.03.019","article-title":"CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma","volume":"49","author":"Nordfors","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.18632\/oncotarget.14796","article-title":"Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic","volume":"8","author":"Oguejiofor","year":"2017","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2013.11.010","article-title":"Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer","volume":"50","author":"Rietbergen","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-13-2585","article-title":"Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer","volume":"20","author":"Sewell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.27699","article-title":"Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways","volume":"132","author":"Slebos","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tranon.2014.11.002","article-title":"Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome","volume":"8","author":"Tertipis","year":"2015","journal-title":"Transl. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tertipis, N., Haeggblom, L., Nordfors, C., Grun, N., Nasman, A., Vlastos, A., Dalianis, T., and Ramqvist, T. (2014). Correlation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095624"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ejca.2015.04.024","article-title":"A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer","volume":"51","author":"Tertipis","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_48","first-page":"2369","article-title":"HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer","volume":"34","author":"Tertipis","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ol.2021.12538","article-title":"Psoriasin expression is associated with survival in patients with human papillomavirus-positive base of tongue squamous cell carcinoma","volume":"21","author":"Zupancic","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pvr.2017.05.002","article-title":"Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years","volume":"4","author":"Haeggblom","year":"2017","journal-title":"Papillomavirus Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00016489.2020.1813906","article-title":"The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer","volume":"141","author":"Hammarstedt","year":"2021","journal-title":"Acta Otolaryngol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejca.2020.08.003","article-title":"Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8\u2014Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas","volume":"139","author":"Marklund","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cam4.2","article-title":"Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer","volume":"1","author":"Marklund","year":"2012","journal-title":"Cancer Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3109\/00016489.2014.886336","article-title":"The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment","volume":"134","author":"Ljokjel","year":"2014","journal-title":"Acta Otolaryngol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.amjoto.2019.05.006","article-title":"The prognostic effect of anatomic subsite in HPV-positive oropharyngeal squamous cell carcinoma","volume":"40","author":"Tham","year":"2019","journal-title":"Am. J. Otolaryngol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas","volume":"33","author":"Huang","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A multicentre cohort study","volume":"17","author":"Huang","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2016.10.015","article-title":"Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014","volume":"70","author":"Carlander","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Floros, P., Rao, A., McCloy, R.A., Sim, H.W., Chin, V.T., Leavers, B.C., Crawford, J.A., and Gallagher, R.M. (2021). Altered presentation of oropharyngeal cancer, a 6-year review. ANZ J. Surg.","DOI":"10.1111\/ans.16537"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/joim.13010","article-title":"A global epidemic increase of an HPV-induced tonsil and tongue base cancer\u2014Potential benefit from a pan-gender use of HPV vaccine","volume":"287","author":"Nasman","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.oraloncology.2010.08.011","article-title":"Oropharyngeal squamous cell carcinoma: A unique disease on the rise?","volume":"46","author":"Balm","year":"2010","journal-title":"Oral Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.11371","article-title":"Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors","volume":"107","author":"Dahlgren","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_65","first-page":"4375","article-title":"P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma","volume":"25","author":"Lindquist","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_66","first-page":"2821","article-title":"Human papillomavirus and DNA ploidy in tonsillar cancer--correlation to prognosis","volume":"23","author":"Mellin","year":"2003","journal-title":"Anticancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","article-title":"The human papillomavirus family and its role in carcinogenesis","volume":"26","author":"Tommasino","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen","volume":"121","author":"Smeets","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.oraloncology.2018.01.010","article-title":"Double positivity for HPV-DNA\/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients","volume":"78","author":"Mena","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_71","unstructured":"(2021, April 07). Oropharyngeal Cancer. Available online: https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/hn-oropharyngeal-patient.pdf."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.oraloncology.2016.02.001","article-title":"Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy","volume":"55","author":"Kraaijenga","year":"2016","journal-title":"Oral Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s40064-016-2295-1","article-title":"Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC)","volume":"5","author":"Loorents","year":"2016","journal-title":"Springerplus"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Wan Leung, S., Lee, T.F., Chien, C.Y., Chao, P.J., Tsai, W.L., and Fang, F.M. (2011). Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-128"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1017\/S0022215117001098","article-title":"Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer","volume":"131","author":"Qualliotine","year":"2017","journal-title":"J. Laryngol. Otol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0194599820950718","article-title":"Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer","volume":"164","author":"Sauder","year":"2021","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.ejca.2014.07.001","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials","volume":"50","author":"Masterson","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-43580-0_20","article-title":"Update on De-intensification and Intensification Studies in HPV","volume":"206","author":"Mehanna","year":"2017","journal-title":"HPV Infection in Head and Neck Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0140-6736(92)90662-M","article-title":"Clonal p53 mutation in primary cervical cancer: Association with human-papillomavirus-negative tumours","volume":"339","author":"Crook","year":"1992","journal-title":"Lancet"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Wilting, S.M., Smeets, S.J., Snijders, P.J., van Wieringen, W.N., van de Wiel, M.A., Meijer, G.A., Ylstra, B., Leemans, C.R., Meijer, C.J., and Brakenhoff, R.H. (2009). Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Med. Genomics, 2.","DOI":"10.1186\/1755-8794-2-32"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2016.02.009","article-title":"Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma","volume":"118","author":"Hong","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-230X(05)93002-9","article-title":"Presence and influence of human papillomaviruses (HPV) in Tonsillar cancer","volume":"93","author":"Dahlstrand","year":"2005","journal-title":"Adv. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.11389","article-title":"A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16\/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5\u20138","volume":"107","author":"Hafkamp","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ijc.11381","article-title":"Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck","volume":"107","author":"Koskinen","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.10669","article-title":"Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer","volume":"102","author":"Mellin","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.oraloncology.2015.09.007","article-title":"Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters","volume":"51","author":"Ramqvist","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"545385","DOI":"10.3389\/fonc.2020.545385","article-title":"The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma","volume":"10","author":"Welters","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-019-0497-0","article-title":"Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses","volume":"7","author":"Santegoets","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/bjc.2014.446","article-title":"Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences","volume":"111","author":"Balermpas","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hed.25442","article-title":"HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer","volume":"41","author":"Cioni","year":"2019","journal-title":"Head Neck"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Santegoets, S.J., Duurland, C.L., Jordanova, E.J., van Ham, V.J., Ehsan, I., Loof, N.M., Narang, V., Dutertre, C.A., Ginhoux, F., and van Egmond, S.L. (2020). CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer. J. Immunother. Cancer, 8.","DOI":"10.1136\/jitc-2020-001053"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104516","DOI":"10.1016\/j.oraloncology.2019.104516","article-title":"Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma","volume":"101","author":"Young","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.onc.1210798","article-title":"High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells","volume":"27","author":"Bottley","year":"2008","journal-title":"Oncogene"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbrc.2006.08.182","article-title":"HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter","volume":"349","author":"Li","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00066-014-0605-5","article-title":"Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis","volume":"190","author":"Arenz","year":"2014","journal-title":"Strahlenther. Onkol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","article-title":"Enhanced radiation sensitivity in HPV-positive head and neck cancer","volume":"73","author":"Kimple","year":"2013","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","article-title":"HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Haeggblom, L., Nordfors, C., Tertipis, N., Bersani, C., Ramqvist, T., Nasman, A., and Dalianis, T. (2017). Effects of irradiation on human leukocyte antigen class I expression in human papillomavirus positive and negative base of tongue and mobile tongue squamous cell carcinoma cell lines. Int. J. Oncol., 50.","DOI":"10.3892\/ijo.2017.3916"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archoto.2009.159","article-title":"Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer","volume":"135","author":"Spanos","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Nannapaneni, S., Griffith, C.C., Magliocca, K.R., Chen, W., Lyu, X., Chen, Z., Wang, D., Wang, X., Shin, D.M., and Chen, Z.G. (2021). Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247498"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576\u2013582.","DOI":"10.1038\/nature14129"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/annonc\/mdv109","article-title":"Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing","volume":"26","author":"Chung","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Gaykalova, D.A., Mambo, E., Choudhary, A., Houghton, J., Buddavarapu, K., Sanford, T., Darden, W., Adai, A., Hadd, A., and Latham, G. (2014). Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093102"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/2159-8290.CD-13-0103","article-title":"Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers","volume":"3","author":"Lui","year":"2013","journal-title":"Cancer Discov."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1158\/1078-0432.CCR-14-1101","article-title":"Genomic landscape of human papillomavirus-associated cancers","volume":"21","author":"Rusan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cam4.3741","article-title":"Mutation patterns in recurrent and\/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status","volume":"10","author":"Reder","year":"2021","journal-title":"Cancer Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.21873\/anticanres.12774","article-title":"Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome","volume":"38","author":"Bersani","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-4598-4-15","article-title":"Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation","volume":"4","author":"Rosty","year":"2005","journal-title":"Mol. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.febslet.2014.04.017","article-title":"Mutant p53 reactivation by small molecules makes its way to the clinic","volume":"588","author":"Bykov","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_114","unstructured":"Duffy, M.J., Synnott, N.C., O\u2019Grady, S., and Crown, J. (2020). Targeting p53 for the treatment of cancer. Semin. Cancer Biol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Isaacsson Velho, P.H., Castro, G., and Chung, C.H. (2015). Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma. Am. Soc. Clin. Oncol. Educ. Book, 123\u2013128.","DOI":"10.14694\/EdBook_AM.2015.35.123"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Leenhardt, F., Alexandre, M., and Jacot, W. (2021). Alpelisib for the treatment of PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer. Expert Opin. Pharmacother., 1\u20139.","DOI":"10.1080\/14656566.2021.1873952"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2014.60.7341","article-title":"Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors","volume":"33","author":"Tabernero","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cncr.27696","article-title":"A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma","volume":"119","author":"Gao","year":"2013","journal-title":"Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: Bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/bjc.2011.29","article-title":"Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: A prospective translational study","volume":"104","author":"Lajer","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergen.2018.10.004","article-title":"Identification of eight meta-signature miRNAs as potential biomarkers for oropharyngeal cancers","volume":"233\u2013234","author":"Li","year":"2019","journal-title":"Cancer Genet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajpath.2014.11.018","article-title":"Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas","volume":"185","author":"Miller","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.oraloncology.2014.07.019","article-title":"A predictive transcriptomic signature of oropharyngeal cancer according to HPV16 status exclusively","volume":"50","author":"Mirghani","year":"2014","journal-title":"Oral Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/hed.24487","article-title":"Comparative analysis of micro-RNAs in human papillomavirus-positive versus -negative oropharyngeal cancers","volume":"38","author":"Mirghani","year":"2016","journal-title":"Head Neck"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Harden, M.E., Prasad, N., Griffiths, A., and Munger, K. (2017). Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins. mBio, 8.","DOI":"10.1128\/mBio.02170-16"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejca.2006.09.001","article-title":"Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas","volume":"43","author":"Martinez","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Ramqvist, T., Nasman, A., Franzen, B., Bersani, C., Alexeyenko, A., Becker, S., Haeggblom, L., Kolev, A., Dalianis, T., and Munck-Wikland, E. (2018). Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19040978"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Chen, Z., Wong, P.Y., Ng, C.W.K., Lan, L., Fung, S., Li, J.W., Cai, L., Lei, P., Mou, Q., and Wong, S.H. (2020). The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12113425"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"51320","DOI":"10.18632\/oncotarget.9710","article-title":"16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment","volume":"7","author":"Jedlicka","year":"2016","journal-title":"Oncotarget"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jamaoncol.2017.4777","article-title":"Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer","volume":"4","author":"Hayes","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41522-020-00146-8","article-title":"Vaginal microbiota and human papillomavirus infection among young Swedish women","volume":"6","author":"Cheng","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40168-016-0203-0","article-title":"The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: What do we know and where are we going next?","volume":"4","author":"Mitra","year":"2016","journal-title":"Microbiome"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41199-018-0030-z","article-title":"Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)","volume":"3","author":"Jung","year":"2018","journal-title":"Cancers Head Neck"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Morgan, E.L., Chen, Z., and Van Waes, C. (2020). Regulation of NFkappaB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?. Cancers, 12.","DOI":"10.3390\/cancers12102877"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Agostinetto, E., Debien, V., Marta, G.N., Lambertini, M., Piccart-Gebhart, M., and de Azambuja, E. (2021). CDK4\/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer. Eur. J. Clin. Investig., e13535.","DOI":"10.1111\/eci.13535"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer","volume":"380","author":"Andre","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/1078-0432.CCR-18-3334","article-title":"Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors","volume":"25","author":"Bahleda","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17425255.2021.1844662","article-title":"A pharmacokinetic evaluation of alpelisib for the treatment of HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer","volume":"17","author":"Bertho","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Kardoust Parizi, M., Margulis, V., Lotan, Y., Mori, K., and Shariat, S.F. (2021). Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. Urol. Oncol.","DOI":"10.1016\/S2666-1683(21)03219-5"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-020-01320-8","article-title":"Targeting activated PI3K\/mTOR signaling overcomes acquired resistance to CDK4\/6-based therapies in preclinical models of hormone receptor-positive breast cancer","volume":"22","author":"McDermott","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_142","first-page":"1951","article-title":"Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and-negative SCC","volume":"35","author":"Aderhold","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_143","first-page":"175","article-title":"In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer","volume":"35","author":"Keam","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2013.09.007","article-title":"Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models","volume":"343","author":"Ma","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_145","first-page":"6249","article-title":"In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines","volume":"18","author":"Holzhauser","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_146","first-page":"1616","article-title":"Combined inhibition of FGFR and mTOR pathways is effective in suppressing ovarian cancer","volume":"11","author":"Cai","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Holzhauser, S., Wild, N., Zupancic, M., Ursu, R.G., Bersani, C., Nasman, A., Kostopoulou, O.N., and Dalianis, T. (2021). Targeted therapy with PI3K and FGFR inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer lines with and without corresponding mutations. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.640490"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41419-020-03126-0","article-title":"Metformin as a senostatic drug enhances the anticancer efficacy of CDK4\/6 inhibitor in head and neck squamous cell carcinoma","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.18632\/oncotarget.7543","article-title":"The CDK4\/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma","volume":"7","author":"Ku","year":"2016","journal-title":"Oncotarget"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41419-019-2098-8","article-title":"Cisplatin exposure causes c-Myc-dependent resistance to CDK4\/6 inhibition in HPV-negative head and neck squamous cell carcinoma","volume":"10","author":"Robinson","year":"2019","journal-title":"Cell Death Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/910\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:00:55Z","timestamp":1760162455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":150,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["v13050910"],"URL":"https:\/\/doi.org\/10.3390\/v13050910","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]}}}